Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Identification of CSF bio… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

Artikel i vetenskaplig tidskrift
Författare Ulla Rüetschi
Henrik Zetterberg
Vladimir N Podust
Johan Gottfries
Susann Li
Anja Hviid Simonsen
James McGuire
Mats Karlsson
Lars Rymo
Huw Davies
Lennart Minthon
Kaj Blennow
Publicerad i Experimental neurology
Volym 196
Nummer/häfte 2
Sidor 273-81
ISSN 0014-4886
Publiceringsår 2005
Publicerad vid Institutionen för klinisk neurovetenskap, Sektionen för laborativ neurovetenskap
Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi/transfusionsmedicin
Sidor 273-81
Språk en
Länkar dx.doi.org/10.1016/j.expneurol.2005...
Ämnesord Adult, Aged, Aged, 80 and over, Amyloid beta-Protein, metabolism, Biological Markers, analysis, cerebrospinal fluid, Brain Chemistry, physiology, Dementia, cerebrospinal fluid, Enzyme-Linked Immunosorbent Assay, methods, Female, Humans, Male, Middle Aged, Multivariate Analysis, Peptide Fragments, metabolism, Reproducibility of Results, Sequence Analysis, Protein, methods, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, methods, tau Proteins, cerebrospinal fluid
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

This investigation describes the discovery of novel possible cerebrospinal fluid (CSF) biomarkers for frontotemporal dementia (FTD) using surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS). Sixteen clinically diagnosed FTD patients and 12 non-demented controls were included in the study. CSF was collected and analyzed for protein expression by SELDI-TOF MS. The samples were analyzed on four different array surfaces using two different energy-absorbing molecules as matrices. In total each sample was subjected to eight different surface/matrix conditions. About 2000 protein peaks (mass/charge ratios) were detected. Forty-two peaks were differentially expressed in FTD (P < 0.01). After exclusion of peaks with low signal-to-noise ratio and/or poor resolution and peaks representing differentially charged proteins, 10 peaks remained, five of which were increased and five decreased in FTD cases compared to controls. Using partial least square discriminant analysis (PLS-DA), the combination of these biomarkers discriminated FTD from non-demented controls with a sensitivity of 94%, a specificity of 83% and an accuracy of 89%. Five of the peaks were purified further and identified by tandem MS as a fragment of neurosecretory protein VGF, transthyretin, S-cysteinylated transthyretin, truncated cystatin C and a fragment of chromogranin B. With use of these potential biomarkers, FTD can be distinguished from control subjects with high accuracy in this pilot study.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?